Ilaria Zanetti Selected Research

Drug Therapy (Chemotherapy)

1/2022	Therapy and prognostic significance of regional lymph node involvement in embryonal rhabdomyosarcoma: a report from the European paediatric Soft tissue sarcoma Study Group.
1/2021	Embryonal rhabdomyosarcoma completely resected at diagnosis: The European paediatric Soft tissue sarcoma Study Group RMS2005 experience.
1/2021	Alveolar rhabdomyosarcoma with regional nodal involvement: Results of a combined analysis from two cooperative groups.
11/2019	Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
10/2019	Outcome and prognostic factors in pediatric malignant peripheral nerve sheath tumors: An analysis of the European Pediatric Soft Tissue Sarcoma Group (EpSSG) NRSTS-2005 prospective study.
4/2019	Topotecan/carboplatin regimen for refractory/recurrent rhabdomyosarcoma in children: Report from the AIEOP Soft Tissue Sarcoma Committee.
1/2018	Alveolar soft part sarcoma in children and adolescents: The European Paediatric Soft Tissue Sarcoma study group prospective trial (EpSSG NRSTS 2005).
1/2018	Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).
12/2017	The EpSSG NRSTS 2005 treatment protocol for desmoid-type fibromatosis in children: an international prospective case series.
11/2005	Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilaria Zanetti Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 04/2004
9	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 12/2017
6	Rhabdomyosarcoma 01/2022 - 04/2019
3	Alveolar Rhabdomyosarcoma 01/2022 - 04/2019
2	Embryonal Rhabdomyosarcoma 01/2022 - 12/2017
2	Residual Neoplasm 01/2022 - 11/2005
2	Neurofibrosarcoma (MPNST) 10/2019 - 11/2005
1	Malignant mesenchymal tumor 01/2022
1	Seizures (Absence Seizure) 01/2021
1	Thrombocytopenia (Thrombopenia) 11/2019
1	Infections 11/2019
1	Neutropenia 11/2019
1	Pain (Aches) 11/2019
1	Fibroma (Fibromatosis) 12/2017
1	Aggressive Fibromatosis (Desmoid) 12/2017
1	Water Intoxication 02/2008
1	Body Weight (Weight, Body) 05/2003

Drug/Important Bio-Agent (IBA)

4	Ifosfamide FDA LinkGeneric 01/2021 - 02/2008
3	AutoantibodiesIBA 01/2022 - 02/2020
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2019 - 01/2018
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022
1	Fibroblast Growth Factor 8IBA 01/2022
1	AutoantigensIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Gamma-protocadherinsIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	AntigensIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2019
1	Vasopressins (Vasopressin)IBA 11/2019
1	Topotecan (Hycamtin)FDA LinkGeneric 04/2019
1	Carboplatin (JM8)FDA LinkGeneric 04/2019
1	penicillamine-glutathione mixed disulfideIBA 01/2019
1	Biological ProductsIBA 08/2016
1	Mesna (Coenzyme M)FDA LinkGeneric 02/2008

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
5	Radiotherapy 11/2022 - 11/2005
5	Therapeutics 11/2022 - 01/2020
3	Neoadjuvant Therapy 12/2020 - 11/2005
1	Induction Chemotherapy 12/2020
1	Maintenance Chemotherapy 11/2019
1	Adjuvant Chemotherapy 10/2019
1	Adjuvant Radiotherapy 10/2019
1	Conservative Treatment 12/2017
1	Length of Stay 02/2008